APO Research
Talk to an analyst

APO RESEARCH · REPORT

Metabolomics Mixes and Kits

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Metabolomics Mixes and Kits Market Outlook and Growth Opportunities 2026

5 June 2026190 pages

Choose your research edition.

Industry ResearchMetabolomics Mixes and Kits Industry Research Report 2026112 pages · $2,950 USDIndustry Growth & TrendsGlobal Metabolomics Mixes and Kits Industry Growth and Trends Forecast to 203286 pages · $3,450 USDMarket StructureGlobal Metabolomics Mixes and Kits Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Metabolomics Mixes and Kits Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Metabolomics Mixes and Kits Market Analysis and Forecast 2026-2032231 pages · $4,950 USD

Market perspective

The global Metabolomics Mixes and Kits market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Metabolomics Mixes and Kits is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Metabolomics Mixes and Kits is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Metabolomics Mixes and Kits is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Metabolomics Mixes and Kits market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Metabolomics Mixes and Kits market include Cambridge Isotope Laboratories, Merck KGaA, Biocrates, Thermo Fisher Scientific, Fluidome and Metabolomix, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Metabolomics Mixes and Kits market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Metabolomics Mixes and Kits and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Metabolomics Mixes and Kits revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Metabolomics Mixes and Kits market.

Metabolomics Mixes and Kits Segment by Company

Cambridge Isotope Laboratories

Merck KGaA

Biocrates

Thermo Fisher Scientific

Fluidome

Metabolomix

Metabolomics Mixes and Kits Segment by Type

Lipid Metabolism

Amino Acid Metabolism

Carbohydrate Metabolism

Bacterial Metabolism

Other

Metabolomics Mixes and Kits Segment by Application

Biological Companies

Research Institutions

Educational Institutions

Metabolomics Mixes and Kits Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Metabolomics Mixes and Kits status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Metabolomics Mixes and Kits key companies, revenue, market share, and recent developments.

3. To split the Metabolomics Mixes and Kits breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Metabolomics Mixes and Kits market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Metabolomics Mixes and Kits significant trends, drivers, influence factors in global and regions.

6. To analyze Metabolomics Mixes and Kits competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Metabolomics Mixes and Kits market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Metabolomics Mixes and Kits and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Metabolomics Mixes and Kits.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Metabolomics Mixes and Kits industry.

Chapter 3: Detailed analysis of Metabolomics Mixes and Kits company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Metabolomics Mixes and Kits in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Metabolomics Mixes and Kits in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Metabolomics Mixes and Kits Industry Trends Table 2. Metabolomics Mixes and Kits Industry Drivers Table 3. Metabolomics Mixes and Kits Industry Opportunities and Challenges Table 4. Metabolomics Mixes and Kits Industry Restraints Table 5. Global Metabolomics Mixes and Kits Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Metabolomics Mixes and Kits Revenue Share by Company (2021-2026) Table 7. Global Metabolomics Mixes and Kits Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Metabolomics Mixes and Kits Key Company Manufacturing Base & Headquarters Table 9. Global Metabolomics Mixes and Kits Company, Product Type & Application Table 10. Global Metabolomics Mixes and Kits Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Metabolomics Mixes and Kits by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Lipid Metabolism Table 15. Significant Companies of Amino Acid Metabolism Table 16. Significant Companies of Carbohydrate Metabolism Table 17. Significant Companies of Bacterial Metabolism Table 18. Significant Companies of Other Table 19. Global Metabolomics Mixes and Kits Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 20. Global Metabolomics Mixes and Kits Sales Value by Type (2021-2026) & (US$ Million) Table 21. Global Metabolomics Mixes and Kits Sales Value by Type (2027-2032) & (US$ Million) Table 22. Global Metabolomics Mixes and Kits Sales Value Share by Type (2021-2026) Table 23. Global Metabolomics Mixes and Kits Sales Value Share by Type (2027-2032) Table 24. Significant Companies of Biological Companies Table 25. Significant Companies of Research Institutions Table 26. Significant Companies of Educational Institutions Table 27. Global Metabolomics Mixes and Kits Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Metabolomics Mixes and Kits Sales Value by Application (2021-2026) & (US$ Million) Table 29. Global Metabolomics Mixes and Kits Sales Value by Application (2027-2032) & (US$ Million) Table 30. Global Metabolomics Mixes and Kits Sales Value Share by Application (2021-2026) Table 31. Global Metabolomics Mixes and Kits Sales Value Share by Application (2027-2032) Table 32. Global Metabolomics Mixes and Kits Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Metabolomics Mixes and Kits Sales Value by Region (2021-2026) & (US$ Million) Table 34. Global Metabolomics Mixes and Kits Sales Value Share by Region (2021-2026) Table 35. Global Metabolomics Mixes and Kits Sales Value by Region (2027-2032) & (US$ Million) Table 36. Global Metabolomics Mixes and Kits Sales Value Share by Region (2027-2032) Table 37. Global Metabolomics Mixes and Kits Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Metabolomics Mixes and Kits Sales Value by Country (2021-2026) & (US$ Million) Table 39. Global Metabolomics Mixes and Kits Sales Value Market Share by Country (2021-2026) Table 40. Global Metabolomics Mixes and Kits Sales Value by Country (2027-2032) & (US$ Million) Table 41. Global Metabolomics Mixes and Kits Sales Value Market Share by Country (2027-2032) Table 42. Cambridge Isotope Laboratories Company Information Table 43. Cambridge Isotope Laboratories Business Overview Table 44. Cambridge Isotope Laboratories Metabolomics Mixes and Kits Revenue (US$ Million) and Gross Margin (2021-2026) Table 45. Cambridge Isotope Laboratories Metabolomics Mixes and Kits Product Portfolio Table 46. Cambridge Isotope Laboratories Recent Development Table 47. Merck KGaA Company Information Table 48. Merck KGaA Business Overview Table 49. Merck KGaA Metabolomics Mixes and Kits Revenue (US$ Million) and Gross Margin (2021-2026) Table 50. Merck KGaA Metabolomics Mixes and Kits Product Portfolio Table 51. Merck KGaA Recent Development Table 52. Biocrates Company Information Table 53. Biocrates Business Overview Table 54. Biocrates Metabolomics Mixes and Kits Revenue (US$ Million) and Gross Margin (2021-2026) Table 55. Biocrates Metabolomics Mixes and Kits Product Portfolio Table 56. Biocrates Recent Development Table 57. Thermo Fisher Scientific Company Information Table 58. Thermo Fisher Scientific Business Overview Table 59. Thermo Fisher Scientific Metabolomics Mixes and Kits Revenue (US$ Million) and Gross Margin (2021-2026) Table 60. Thermo Fisher Scientific Metabolomics Mixes and Kits Product Portfolio Table 61. Thermo Fisher Scientific Recent Development Table 62. Fluidome Company Information Table 63. Fluidome Business Overview Table 64. Fluidome Metabolomics Mixes and Kits Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Fluidome Metabolomics Mixes and Kits Product Portfolio Table 66. Fluidome Recent Development Table 67. Metabolomix Company Information Table 68. Metabolomix Business Overview Table 69. Metabolomix Metabolomics Mixes and Kits Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Metabolomix Metabolomics Mixes and Kits Product Portfolio Table 71. Metabolomix Recent Development Table 72. Research Programs/Design for This Report Table 73. Authors List of This Report Table 74. Secondary Sources Table 75. Primary Sources List of Figures Figure 1. Metabolomics Mixes and Kits Product Image Figure 2. Global Metabolomics Mixes and Kits Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Metabolomics Mixes and Kits Market Size (2021-2032) & (US$ Million) Figure 4. Global Metabolomics Mixes and Kits Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Lipid Metabolism Image Figure 8. Amino Acid Metabolism Image Figure 9. Carbohydrate Metabolism Image Figure 10. Bacterial Metabolism Image Figure 11. Other Image Figure 12. Global Metabolomics Mixes and Kits Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 13. Global Metabolomics Mixes and Kits Sales Value Share 2021 VS 2025 VS 2032 Figure 14. Global Metabolomics Mixes and Kits Sales Value Share by Type (2021-2032) Figure 15. Biological Companies Image Figure 16. Research Institutions Image Figure 17. Educational Institutions Image Figure 18. Global Metabolomics Mixes and Kits Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Metabolomics Mixes and Kits Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Metabolomics Mixes and Kits Sales Value Share by Application (2021-2032) Figure 21. Global Metabolomics Mixes and Kits Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 22. Global Metabolomics Mixes and Kits Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 23. North America Metabolomics Mixes and Kits Sales Value (2021-2032) & (US$ Million) Figure 24. North America Metabolomics Mixes and Kits Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Europe Metabolomics Mixes and Kits Sales Value (2021-2032) & (US$ Million) Figure 26. Europe Metabolomics Mixes and Kits Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Asia-Pacific Metabolomics Mixes and Kits Sales Value (2021-2032) & (US$ Million) Figure 28. Asia-Pacific Metabolomics Mixes and Kits Sales Value Share by Country (%), 2025 VS 2032 Figure 29. South America Metabolomics Mixes and Kits Sales Value (2021-2032) & (US$ Million) Figure 30. South America Metabolomics Mixes and Kits Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Middle East & Africa Metabolomics Mixes and Kits Sales Value (2021-2032) & (US$ Million) Figure 32. Middle East & Africa Metabolomics Mixes and Kits Sales Value Share by Country (%), 2025 VS 2032 Figure 33. USA Metabolomics Mixes and Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. USA Metabolomics Mixes and Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. USA Metabolomics Mixes and Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Canada Metabolomics Mixes and Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Canada Metabolomics Mixes and Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Canada Metabolomics Mixes and Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Mexico Metabolomics Mixes and Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Mexico Metabolomics Mixes and Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Mexico Metabolomics Mixes and Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Germany Metabolomics Mixes and Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Germany Metabolomics Mixes and Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Germany Metabolomics Mixes and Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. France Metabolomics Mixes and Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. France Metabolomics Mixes and Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. France Metabolomics Mixes and Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. U.K. Metabolomics Mixes and Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. U.K. Metabolomics Mixes and Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. U.K. Metabolomics Mixes and Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Italy Metabolomics Mixes and Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Italy Metabolomics Mixes and Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Italy Metabolomics Mixes and Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Spain Metabolomics Mixes and Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Spain Metabolomics Mixes and Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Spain Metabolomics Mixes and Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Russia Metabolomics Mixes and Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Russia Metabolomics Mixes and Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Russia Metabolomics Mixes and Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Netherlands Metabolomics Mixes and Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Netherlands Metabolomics Mixes and Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Netherlands Metabolomics Mixes and Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Nordic Countries Metabolomics Mixes and Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Nordic Countries Metabolomics Mixes and Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Nordic Countries Metabolomics Mixes and Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. China Metabolomics Mixes and Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. China Metabolomics Mixes and Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. China Metabolomics Mixes and Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Japan Metabolomics Mixes and Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Japan Metabolomics Mixes and Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Japan Metabolomics Mixes and Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. South Korea Metabolomics Mixes and Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. South Korea Metabolomics Mixes and Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. South Korea Metabolomics Mixes and Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. India Metabolomics Mixes and Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. India Metabolomics Mixes and Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. India Metabolomics Mixes and Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Australia Metabolomics Mixes and Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Australia Metabolomics Mixes and Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Australia Metabolomics Mixes and Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Southeast Asia Metabolomics Mixes and Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Southeast Asia Metabolomics Mixes and Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Southeast Asia Metabolomics Mixes and Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Brazil Metabolomics Mixes and Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Brazil Metabolomics Mixes and Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Brazil Metabolomics Mixes and Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Argentina Metabolomics Mixes and Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Argentina Metabolomics Mixes and Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Argentina Metabolomics Mixes and Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Chile Metabolomics Mixes and Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Chile Metabolomics Mixes and Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Chile Metabolomics Mixes and Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Colombia Metabolomics Mixes and Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Colombia Metabolomics Mixes and Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Colombia Metabolomics Mixes and Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Peru Metabolomics Mixes and Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Peru Metabolomics Mixes and Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Peru Metabolomics Mixes and Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Metabolomics Mixes and Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Saudi Arabia Metabolomics Mixes and Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Saudi Arabia Metabolomics Mixes and Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Israel Metabolomics Mixes and Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Israel Metabolomics Mixes and Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Israel Metabolomics Mixes and Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. UAE Metabolomics Mixes and Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. UAE Metabolomics Mixes and Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. UAE Metabolomics Mixes and Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Turkey Metabolomics Mixes and Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Turkey Metabolomics Mixes and Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Turkey Metabolomics Mixes and Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Iran Metabolomics Mixes and Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Iran Metabolomics Mixes and Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Iran Metabolomics Mixes and Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Egypt Metabolomics Mixes and Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Egypt Metabolomics Mixes and Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Egypt Metabolomics Mixes and Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Years Considered Figure 118. Research Process Figure 119. Key Executives Interviewed

Scope & coverage.

Types
  • Lipid Metabolism
  • Amino Acid Metabolism
  • Carbohydrate Metabolism
  • Bacterial Metabolism
  • Other
Applications
  • Biological Companies
  • Research Institutions
  • Educational Institutions
Companies covered
  • Cambridge Isotope Laboratories
  • Merck KGaA
  • Biocrates
  • Thermo Fisher Scientific
  • Fluidome
  • Metabolomix

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Metabolomics Mixes and Kits Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Metabolomics Mixes and Kits Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Metabolomics Mixes and Kits Market Dynamics
  1. 2.1 Metabolomics Mixes and Kits Industry Trends
  2. 2.2 Metabolomics Mixes and Kits Industry Drivers
  3. 2.3 Metabolomics Mixes and Kits Industry Opportunities and Challenges
  4. 2.4 Metabolomics Mixes and Kits Industry Restraints
3 Metabolomics Mixes and Kits Market by Company
  1. 3.1 Global Metabolomics Mixes and Kits Company Revenue Ranking in 2025
  2. 3.2 Global Metabolomics Mixes and Kits Revenue by Company (2021-2026)
  3. 3.3 Global Metabolomics Mixes and Kits Company Ranking (2024-2026)
  4. 3.4 Global Metabolomics Mixes and Kits Company Manufacturing Base and Headquarters
  5. 3.5 Global Metabolomics Mixes and Kits Company Product Type and Application
  6. 3.6 Global Metabolomics Mixes and Kits Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Metabolomics Mixes and Kits Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Metabolomics Mixes and Kits Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Metabolomics Mixes and Kits Market by Type
  1. 4.1 Metabolomics Mixes and Kits Type Introduction
  2. 4.1.1 Lipid Metabolism
  3. 4.1.2 Amino Acid Metabolism
  4. 4.1.3 Carbohydrate Metabolism
  5. 4.1.4 Bacterial Metabolism
  6. 4.1.5 Other
  7. 4.2 Global Metabolomics Mixes and Kits Sales Value by Type
  8. 4.2.1 Global Metabolomics Mixes and Kits Sales Value by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Metabolomics Mixes and Kits Sales Value by Type (2021-2032)
  10. 4.2.3 Global Metabolomics Mixes and Kits Sales Value Share by Type (2021-2032)
5 Metabolomics Mixes and Kits Market by Application
  1. 5.1 Metabolomics Mixes and Kits Application Introduction
  2. 5.1.1 Biological Companies
  3. 5.1.2 Research Institutions
  4. 5.1.3 Educational Institutions
  5. 5.2 Global Metabolomics Mixes and Kits Sales Value by Application
  6. 5.2.1 Global Metabolomics Mixes and Kits Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Metabolomics Mixes and Kits Sales Value by Application (2021-2032)
  8. 5.2.3 Global Metabolomics Mixes and Kits Sales Value Share by Application (2021-2032)
6 Metabolomics Mixes and Kits Regional Value Analysis
  1. 6.1 Global Metabolomics Mixes and Kits Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Metabolomics Mixes and Kits Sales Value by Region (2021-2032)
  3. 6.2.1 Global Metabolomics Mixes and Kits Sales Value by Region: 2021-2026
  4. 6.2.2 Global Metabolomics Mixes and Kits Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Metabolomics Mixes and Kits Sales Value (2021-2032)
  7. 6.3.2 North America Metabolomics Mixes and Kits Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Metabolomics Mixes and Kits Sales Value (2021-2032)
  10. 6.4.2 Europe Metabolomics Mixes and Kits Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Metabolomics Mixes and Kits Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Metabolomics Mixes and Kits Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Metabolomics Mixes and Kits Sales Value (2021-2032)
  16. 6.6.2 South America Metabolomics Mixes and Kits Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Metabolomics Mixes and Kits Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Metabolomics Mixes and Kits Sales Value Share by Country, 2025 VS 2032
7 Metabolomics Mixes and Kits Country-level Value Analysis
  1. 7.1 Global Metabolomics Mixes and Kits Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Metabolomics Mixes and Kits Sales Value by Country (2021-2032)
  3. 7.2.1 Global Metabolomics Mixes and Kits Sales Value by Country (2021-2026)
  4. 7.2.2 Global Metabolomics Mixes and Kits Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Metabolomics Mixes and Kits Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Metabolomics Mixes and Kits Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Metabolomics Mixes and Kits Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Metabolomics Mixes and Kits Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Metabolomics Mixes and Kits Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Metabolomics Mixes and Kits Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Metabolomics Mixes and Kits Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Metabolomics Mixes and Kits Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Metabolomics Mixes and Kits Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Metabolomics Mixes and Kits Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Metabolomics Mixes and Kits Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Metabolomics Mixes and Kits Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Metabolomics Mixes and Kits Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Metabolomics Mixes and Kits Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Metabolomics Mixes and Kits Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Metabolomics Mixes and Kits Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Metabolomics Mixes and Kits Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Metabolomics Mixes and Kits Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Metabolomics Mixes and Kits Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Metabolomics Mixes and Kits Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Metabolomics Mixes and Kits Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Metabolomics Mixes and Kits Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Metabolomics Mixes and Kits Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Metabolomics Mixes and Kits Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Metabolomics Mixes and Kits Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Metabolomics Mixes and Kits Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Metabolomics Mixes and Kits Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Metabolomics Mixes and Kits Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Metabolomics Mixes and Kits Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Metabolomics Mixes and Kits Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Metabolomics Mixes and Kits Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Metabolomics Mixes and Kits Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Metabolomics Mixes and Kits Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Metabolomics Mixes and Kits Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Metabolomics Mixes and Kits Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Metabolomics Mixes and Kits Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Metabolomics Mixes and Kits Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Metabolomics Mixes and Kits Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Metabolomics Mixes and Kits Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Metabolomics Mixes and Kits Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Metabolomics Mixes and Kits Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Metabolomics Mixes and Kits Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Metabolomics Mixes and Kits Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Metabolomics Mixes and Kits Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Metabolomics Mixes and Kits Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Metabolomics Mixes and Kits Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Metabolomics Mixes and Kits Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Metabolomics Mixes and Kits Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Metabolomics Mixes and Kits Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Metabolomics Mixes and Kits Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Metabolomics Mixes and Kits Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Metabolomics Mixes and Kits Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Metabolomics Mixes and Kits Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Metabolomics Mixes and Kits Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Metabolomics Mixes and Kits Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Metabolomics Mixes and Kits Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Metabolomics Mixes and Kits Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Metabolomics Mixes and Kits Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Metabolomics Mixes and Kits Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Metabolomics Mixes and Kits Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Metabolomics Mixes and Kits Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Metabolomics Mixes and Kits Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Metabolomics Mixes and Kits Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Metabolomics Mixes and Kits Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Metabolomics Mixes and Kits Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Metabolomics Mixes and Kits Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Metabolomics Mixes and Kits Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Metabolomics Mixes and Kits Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Metabolomics Mixes and Kits Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Metabolomics Mixes and Kits Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Metabolomics Mixes and Kits Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Metabolomics Mixes and Kits Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Metabolomics Mixes and Kits Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Metabolomics Mixes and Kits Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Metabolomics Mixes and Kits Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Metabolomics Mixes and Kits Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Metabolomics Mixes and Kits Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Metabolomics Mixes and Kits Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Metabolomics Mixes and Kits Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Metabolomics Mixes and Kits Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Metabolomics Mixes and Kits Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Metabolomics Mixes and Kits Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Metabolomics Mixes and Kits Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Metabolomics Mixes and Kits Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Cambridge Isotope Laboratories
  2. 8.1.1 Cambridge Isotope Laboratories Company Information
  3. 8.1.2 Cambridge Isotope Laboratories Business Overview
  4. 8.1.3 Cambridge Isotope Laboratories Metabolomics Mixes and Kits Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Cambridge Isotope Laboratories Metabolomics Mixes and Kits Product Portfolio
  6. 8.1.5 Cambridge Isotope Laboratories Recent Developments
  7. 8.2 Merck KGaA
  8. 8.2.1 Merck KGaA Company Information
  9. 8.2.2 Merck KGaA Business Overview
  10. 8.2.3 Merck KGaA Metabolomics Mixes and Kits Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Merck KGaA Metabolomics Mixes and Kits Product Portfolio
  12. 8.2.5 Merck KGaA Recent Developments
  13. 8.3 Biocrates
  14. 8.3.1 Biocrates Company Information
  15. 8.3.2 Biocrates Business Overview
  16. 8.3.3 Biocrates Metabolomics Mixes and Kits Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Biocrates Metabolomics Mixes and Kits Product Portfolio
  18. 8.3.5 Biocrates Recent Developments
  19. 8.4 Thermo Fisher Scientific
  20. 8.4.1 Thermo Fisher Scientific Company Information
  21. 8.4.2 Thermo Fisher Scientific Business Overview
  22. 8.4.3 Thermo Fisher Scientific Metabolomics Mixes and Kits Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Thermo Fisher Scientific Metabolomics Mixes and Kits Product Portfolio
  24. 8.4.5 Thermo Fisher Scientific Recent Developments
  25. 8.5 Fluidome
  26. 8.5.1 Fluidome Company Information
  27. 8.5.2 Fluidome Business Overview
  28. 8.5.3 Fluidome Metabolomics Mixes and Kits Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Fluidome Metabolomics Mixes and Kits Product Portfolio
  30. 8.5.5 Fluidome Recent Developments
  31. 8.6 Metabolomix
  32. 8.6.1 Metabolomix Company Information
  33. 8.6.2 Metabolomix Business Overview
  34. 8.6.3 Metabolomix Metabolomics Mixes and Kits Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Metabolomix Metabolomics Mixes and Kits Product Portfolio
  36. 8.6.5 Metabolomix Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst